Hydrochloride, Tocainide,
Tocainide,
Tocainide Hydrochloride,
Tocainide Monohdyrochloride, (R)-Isomer,
Tocainide Monohydrobromide, (R)-Isomer,
Tocainide Monohydrochloride,
Tocainide Monohydrochloride, (+-)-Isomer,
Tocainide Monohydrochloride, (S)-Isomer,
Tocainide, (+-)-Isomer,
Tocainide, (R)-Isomer,
Tocainide, (S)-Isomer,
Tonocard,
W 36095,
W-36095,
W36095,
Xylotocan,
Tocainide hydrochloride,
Tonocard,
Tocainide HCl,
Taquidil,
71395-14-7,
Tocainide hydrochloride [USP],
35891-93-1,
Propanamide, 2-amino-N-(2,6-dimethylphenyl)-, monohydrochloride,
DSSTox_CID_25540,
DSSTox_RID_80942,
DSSTox_GSID_45540,
Tocainide hydrochloride (USP),
2-Amino-N-(2,6-dimethylphenyl)propanamide hydrochloride,
Xylotocan,
CAS-35891-93-1,
Tocainide-hydrochloride,
(+)-2-Amino-N-(2,6-dimethylphenyl)propanamide monohydrochloride,
Tonocard (TN),
53984-76-2,
EINECS 275-361-2,
AC1Q5LWF,
NCGC00017005-01,
Tocainide Monohydrochloride,
2-Amino-2',6'-propionoxylidide hydrochloride,
SCHEMBL122779,
AC1L33H5,
n-(2,6-dimethylphenyl)alaninamide hydrochloride(1:1),
CHEMBL1200773,
DTXSID5045540,
CTK1H0899,
2-Amino-N-(2,6-dimethylphenyl)propanamide monohydrochloride,
HMS1571M15,
Tocainide (+-)-form hydrochloride,
Tox21_110732,
Tox21_500344,
Tox21_110732_1,
API0008387,
CCG-213604,
LP00344,
ACM35891931,
NCGC00162129-06,
NCGC00261029-01,
LS-119013,
D02088,
Tocainide hydrochloride, >=98% (HPLC), solid,
SR-01000763682,
SR-01000763682-3,
2-amino-N-(2,6-dimethylphenyl)propanamide;hydrochloride,
(1)-2-Amino-N-(2,6-dimethylphenyl)propionamide hydrochloride,
Propanamide, 2-amino-N-(2,6-dimethylphenyl)-, monohydrochloride, (+-)-,
Tocainide hydrochloride, United States Pharmacopeia (USP) Reference Standard,
S-Tonocard,
Tocainidehydrochloride,
UNII-2K7I38CKN5,
UNII-WOY19CV59D,
C11H16N2O.ClH,
C11H16N2O.HCl,
Tocainide S-(+)-form HCl,
2K7I38CKN5,
C11-H16-N2-O.Cl-H,
Tocainide S-(+)-form hydrochloride,
AR-1J7545,
CID108173,
(+-)-2-amino-N-(2,6-dimethylphenyl)propionamide hydrochloride,
74192-59-9,